BIDU-SW
09888
JD HEALTH
06618
ALI HEALTH
00241
NTES-S
09999
JD-SW
09618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 13.73%585.3M | ---- | -67.46%514.65M | ---- | 11.73%1.58B | ---- | 85.16%1.42B | ---- | -31.81%764.42M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -7.53%-35.19M | ---- | 15.18%-32.73M | ---- | 0.54%-38.58M | ---- | -128.20%-38.79M | ---- | -11.94%-17M |
Attributable subsidiary (profit) loss | ---- | 2.25%-30.53M | ---- | 36.35%-31.24M | ---- | 2.02%-49.08M | ---- | -11.47%-50.09M | ---- | -10.00%-44.94M |
Impairment and provisions: | ---- | -73.10%-3.82M | ---- | -87.44%-2.21M | ---- | -100.37%-1.18M | ---- | 3,488.62%316.63M | ---- | -858.36%-9.34M |
-Impairment of trade receivables (reversal) | ---- | ---4.79M | ---- | ---- | ---- | ---- | ---- | 3,555.21%25.53M | ---- | -677.89%-739K |
-Other impairments and provisions | ---- | 143.75%966K | ---- | -87.44%-2.21M | ---- | -100.40%-1.18M | ---- | 3,482.91%291.1M | ---- | -877.84%-8.61M |
Revaluation surplus: | ---- | -22.64%434K | ---- | 0.72%561K | ---- | 15.80%557K | ---- | -69.54%481K | ---- | 508.01%1.58M |
-Fair value of investment properties (increase) | ---- | -22.64%434K | ---- | 0.72%561K | ---- | 15.80%557K | ---- | -69.54%481K | ---- | 508.01%1.58M |
Asset sale loss (gain): | ---- | 1,013.63%13.73M | ---- | -60.82%1.23M | ---- | -50.94%3.15M | ---- | 133.90%6.42M | ---- | -150.06%-18.93M |
-Loss (gain) on sale of property, machinery and equipment | ---- | 1,013.63%13.73M | ---- | -72.79%1.23M | ---- | -29.35%4.53M | ---- | 133.90%6.42M | ---- | -150.06%-18.93M |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---1.39M | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | 6.19%603.06M | ---- | 6.44%567.91M | ---- | 14.26%533.57M | ---- | 13.19%466.99M | ---- | 28.41%412.55M |
-Amortization of intangible assets | ---- | 11.64%84.86M | ---- | -0.55%76.01M | ---- | -7.80%76.42M | ---- | 18.89%82.89M | ---- | 63.40%69.72M |
Financial expense | ---- | 99.18%656.07M | ---- | 73.70%329.38M | ---- | -25.88%189.63M | ---- | -25.68%255.85M | ---- | 26.22%344.25M |
Exchange Loss (gain) | ---- | -89.07%58.02M | ---- | 642.97%530.98M | ---- | 77.36%-97.79M | ---- | -270.87%-431.89M | ---- | -4.80%252.76M |
Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -25.57%43.8M |
Operating profit before the change of operating capital | ---- | -1.68%1.85B | ---- | -11.46%1.88B | ---- | 9.31%2.12B | ---- | 12.25%1.94B | ---- | -14.39%1.73B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 287.63%60.68M | ---- | 60.23%-32.34M | ---- | 2.37%-81.31M | ---- | 37.63%-83.28M | ---- | -8.39%-133.52M |
Developing property (increase)decrease | ---- | -132.10%-61.05M | ---- | 51.26%-26.3M | ---- | -17.65%-53.96M | ---- | -69.56%-45.87M | ---- | ---27.05M |
Accounts receivable (increase)decrease | ---- | -1,584.87%-296.29M | ---- | 109.10%19.95M | ---- | 40.76%-219.28M | ---- | -214.06%-370.15M | ---- | 131.16%324.53M |
Accounts payable increase (decrease) | ---- | 235.50%92.93M | ---- | 73.29%-68.58M | ---- | -129.69%-256.74M | ---- | 630.04%864.63M | ---- | -136.17%-163.13M |
prepayments (increase)decrease | ---- | 415.68%46.09M | ---- | 14.41%-14.6M | ---- | 95.89%-17.06M | ---- | 16.46%-415.09M | ---- | -183.30%-496.86M |
Special items for working capital changes | ---- | 239.06%85.77M | ---- | -111.65%-61.68M | ---- | 151.19%529.57M | ---- | 319.17%210.82M | ---- | -276.94%-96.19M |
Cash from business operations | ---- | 4.73%1.78B | ---- | -16.21%1.69B | ---- | -3.76%2.02B | ---- | 84.89%2.1B | ---- | -4.07%1.14B |
Other taxs | ---- | 8.30%-283.32M | ---- | -27.30%-308.98M | ---- | -5.26%-242.72M | ---- | -20.58%-230.58M | ---- | 44.49%-191.22M |
Interest received - operating | ---- | 26.19%11.87M | ---- | -38.38%9.41M | ---- | 4.71%15.26M | ---- | -14.24%14.58M | ---- | 11.94%17M |
Special items of business | -48.54%317M | ---- | -34.62%615.98M | ---- | 128.77%942.08M | ---- | -33.34%411.81M | ---- | 76.55%617.81M | ---- |
Net cash from operations | -48.54%317M | 7.76%1.5B | -34.62%615.98M | -22.28%1.4B | 128.77%942.08M | -4.80%1.8B | -33.34%411.81M | 95.91%1.89B | 76.55%617.81M | 12.48%962.71M |
Cash flow from investment activities | ||||||||||
Dividend received - investment | ---- | ---- | ---- | ---- | ---- | --33.74M | ---- | ---- | ---- | ---- |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | --60.24M | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | ---- | ---- | ---- | 212.80%48.92M | ---- | -864.27%-43.37M | ---- | -179.20%-4.5M | ---- | 195.91%5.68M |
Sale of fixed assets | ---- | -58.15%27.87M | ---- | 22.36%66.58M | ---- | 141.44%54.41M | ---- | -27.39%22.54M | ---- | -63.45%31.04M |
Purchase of fixed assets | ---- | 23.50%-923.53M | ---- | 20.20%-1.21B | ---- | 19.23%-1.51B | ---- | -18.57%-1.87B | ---- | 25.53%-1.58B |
Purchase of intangible assets | ---- | 90.55%-5.76M | ---- | -160.04%-60.94M | ---- | -3,214.43%-23.43M | ---- | 99.18%-707K | ---- | -12,410.20%-85.82M |
Acquisition of subsidiaries | ---- | 19.96%-63.02M | ---- | -229.82%-78.74M | ---- | -88.04%-23.87M | ---- | 98.34%-12.7M | ---- | -1,054.37%-765.33M |
Cash on investment | ---- | ---- | ---- | 49.40%-86.99M | ---- | -1,576.89%-171.93M | ---- | 81.96%-10.25M | ---- | 15.93%-56.84M |
Other items in the investment business | -16.00%-593.84M | ---- | 32.16%-511.94M | ---- | 14.46%-754.67M | ---- | 23.39%-882.22M | ---- | 45.58%-1.15B | ---- |
Net cash from investment operations | -16.00%-593.84M | 26.85%-964.44M | 32.16%-511.94M | 18.97%-1.32B | 14.46%-754.67M | 13.40%-1.63B | 23.39%-882.22M | 23.35%-1.88B | 45.58%-1.15B | -13.84%-2.45B |
Net cash before financing | -366.07%-276.83M | 600.42%539.3M | -44.48%104.04M | -54.30%77M | 139.84%187.41M | 2,181.15%168.49M | 11.87%-470.41M | 100.50%7.39M | 69.77%-533.79M | -14.73%-1.49B |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | 59.39%7.24B | ---- | -40.93%4.54B | ---- | 21.45%7.69B | ---- | -14.05%6.33B | ---- | 26.57%7.37B |
Refund | ---- | -56.71%-6.45B | ---- | 49.35%-4.12B | ---- | -36.99%-8.13B | ---- | -26.11%-5.93B | ---- | -72.88%-4.7B |
Issuing shares | ---- | ---- | ---- | ---- | ---- | --1.1B | ---- | ---- | ---- | --490K |
Interest paid - financing | ---- | -83.90%-696.17M | ---- | -21.43%-378.56M | ---- | 11.50%-311.75M | ---- | 6.23%-352.27M | ---- | -29.54%-375.68M |
Dividends paid - financing | ---- | 84.50%-72.25M | ---- | -76.35%-466.17M | ---- | -30.98%-264.33M | ---- | 27.91%-201.82M | ---- | -745.70%-279.95M |
Absorb investment income | ---- | -8.38%13.33M | ---- | -42.63%14.55M | ---- | -48.27%25.37M | ---- | 70.25%49.03M | ---- | 392.41%28.8M |
Issuance expenses and redemption of securities expenses | ---- | -774.05%-198.75M | ---- | -136.35%-22.74M | ---- | ---9.62M | ---- | ---- | ---- | ---- |
Other items of the financing business | -131.13%-170.44M | -8,216.94%-81.51M | 479.11%547.45M | 99.25%-980K | -66.24%-144.4M | -74.97%-130.23M | -236.35%-86.87M | -288.83%-74.43M | -97.54%63.71M | 173.30%39.42M |
Net cash from financing operations | -131.13%-170.44M | 42.68%-248.79M | 479.11%547.45M | -903.25%-434.01M | -66.24%-144.4M | 82.86%-43.26M | -236.35%-86.87M | -113.41%-252.46M | -97.54%63.71M | -25.58%1.88B |
Effect of rate | 69.45%-23.62M | 17.40%-104.81M | -22.93%-77.3M | -160.74%-126.88M | -500.36%-62.88M | -156.55%-48.66M | 157.01%15.71M | 199.58%86.06M | -4,293.30%-27.55M | 15.20%-86.42M |
Net Cash | -168.65%-447.27M | 181.37%290.51M | 1,414.89%651.49M | -385.09%-357.01M | 107.72%43.01M | 151.10%125.23M | -18.55%-557.28M | -162.11%-245.07M | -156.79%-470.08M | -67.99%394.57M |
Begining period cash | 13.89%1.52B | -26.57%1.34B | -26.57%1.34B | 4.39%1.82B | 4.39%1.82B | -8.35%1.74B | -8.35%1.74B | 19.32%1.9B | 19.32%1.9B | 243.53%1.6B |
Cash at the end | -44.97%1.05B | 13.89%1.52B | 6.12%1.91B | -26.57%1.34B | 49.74%1.8B | 4.39%1.82B | -14.44%1.2B | -8.35%1.74B | -42.00%1.41B | 19.32%1.9B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.